Table 4 Outcomes at 6 and 12 months for the two cohorts, including mortality, hospitalizations, emergency department (ED) visits, prescription orders, and costs, with significant differences in bold

Mortality

   N, subjects per group

97

97

--

   N, Deaths at 6 months (%)

11 (11%)

25 (26%)

<0.01

   N, Deaths at 12 months (%)

22 (23%)

29 (30%)

0.12

Healthcare utilization

   N, matched subjects per group

97

97

--

   Hospitalizations per 100 patients at 6 months

12.4

13.4

0.84

   ED visits per 100 patients at 6 months

35.1

34.0

0.91

   Prescription orders per patient at 6 months

34.0

31.6

0.69

   Hospitalizations per 100 patients at 12 months

23.2

25.7

0.83

   ED visits per 100 patients at 12 months

69.6

54.3

0.42

   Prescription orders per patient at 12 months

56.5

40.2

0.16

Healthcare costs ^†

   N, matched subjects per group

15

15

--

   Mean pharmacy costs per patient-month (0–6 months)

$100

$175

0.27

   Mean non-pharmacy costs per patient-month (0–6 months)

$3,527

$3,572

0.95

   Mean total costs per patient-month (0–6 months)

$3,627

$3,509

0.89

   Mean pharmacy costs per patient-month (0–12 months)

$69

$141

0.20

   Mean non-pharmacy costs per patient-month (0–12 months)

$1,212

$1,452

0.45

   Mean total costs per patient-month (0–12 months)

$1,281

$1,496

0.52

Quality of life and function at 12 months

   N, matched subjects per group

35

35

--

   Mean EQ-5D index*

0.76

0.73

0.49

   Mean EQ-5D QOL scale**

72

72

0.99

   Harris hip pain/Function score^

73

64

0.04